Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk?

Journal of pediatric and adolescent gynecology

Volumn 24, Issue 2, 2011, Pages 98-101

  Fish, Jonathan D ^a  

^a Steven and Alexandra Cohen Children's Medical Center of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; NEOPLASM; OVARY; PREMATURE OVARIAN FAILURE; RADIATION EXPOSURE; RISK ASSESSMENT; SURVIVOR;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; NEOPLASMS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; RISK ASSESSMENT; SURVIVORS;

MLCS; MLOWN;

EID: 79960940401     PISSN: None     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.11.001     Document Type: Article

References (0)